Kraemer, Brian C.
- Seattle Inst for Biomedical/Clinical Res (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #703
- Top 5% Funded
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$5.2M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#703
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kraemer, Brian C. as a PI. Multi-PI records show the full award amount for context.
- 1RF1AG078335-01A1RF1Contact PITargeting MSUT2 with small molecules to ameliorate pathological tau$2.2Maward amount
- 1RF1AG078374-01A1RF1Contact PISPOP drives neurodegenerative tauopathy$1.8Maward amount
- 1R01AG084680-01R01Contact PIFormation of Tau RNA Complexes disrupts tau function and drives tau neuropathology$638.8Kaward amount
- 5R01AG066211-04R01Contact PIProtection from pathological tau by activation of the ER unfolded protein response$520Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kraemer, Brian C. as a PI.
FY2023 award administered by Seattle Inst for Biomedical/Clinical Res (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardSeattle Inst for Biomedical/Clinical Res
- 2010$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2014R01 Grant Holder
- 2015$2M Cumulative Funding
- 2017$5M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #1043
- 2017Entered Top 25% NationallyRanked #1043
- 2017Entered Top 10% NationallyRanked #1043
- 2022$10M Cumulative Funding
- 2023Entered Top 5% NationallyRanked #703